AzTrials
AzTrials

Post Surgical Pat., Medical Pat., Resp. Failure, Car.Arrest, DeathNCT00875602

Evaluation of EverOn™ - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion

A study testing EverOn (EarlySense) contactless monitoring device in people with Post Surgical Pat., Medical Pat., Resp. Failure, Car.Arrest, Death, run by EarlySense Ltd. at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Evaluation of continuous monitoring device on patients Risk during hospitalization and nurse satisfaction level. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
EverOn (EarlySense) contactless monitoring device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Apr 2009to not given
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Hospitalized patients

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

United States1 site
  • CHMC

    Los Angeles, California, 90015

Other trials in United States

About this study

Evaluation of continuous monitoring device on patients Risk during hospitalization and nurse satisfaction level.

Read the detailed description

To assess the effects of continuous patient monitoring using a contactless monitor in a medical-surgical unit on transfers and length of stay at higher level of care units

Being tested
EverOn (EarlySense) contactless monitoring device
Keywords
All hospitalized patients in a general Med/ Surg unit
Medical subject headings
Death

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EverOn (EarlySense) contactless monitoring deviceDevice

    Hospitalized patients on the study unit are monitored by a contactless device

Study groups in NCT00875602
Study groupRoleWhat they receive
controlNo interventionbefore-after (retrospective) and concurrent controls as comparators with a prospective intervention group
Study unitActive comparatorHospitalized patients in the study group will be continously monitored / supervised by the contact-free device
Receives: Device: EverOn (EarlySense) contactless monitoring device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evidence of benefit to caregivers and patients

    Measured: 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2009 (estimated)
  2. Study startApr 2009

Why it stopped: NO need

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00875602
Sponsor's protocol ID
CHW ES-MRK-PROT-6
Status last verified
Oct 2012
First submitted
2 Apr 2009
Last updated
6 Dec 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing EverOn (EarlySense) contactless monitoring device in people with Post Surgical Pat., Medical Pat., Resp. Failure, Car.Arrest, Death, run by EarlySense Ltd. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 6 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evidence of benefit to caregivers and patients (time frame: 12 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in